Brief: InDex Pharmaceuticals Q1 EBIT SEK -5.3 Million

Flerie AB

26/04/2024 07:01

Apr 26 (Reuters) - InDex Pharmaceuticals Q1 sales SEK 10.8 million.
* Q1 cash flow from operating activities SEK -33.7 million
* Q1 adjusted EPS SEK -0.01
* Q1 net income SEK -3 million